Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Brumar89 who wrote (979066)	11/5/2016 12:53:42 PM
From: zax	Read Replies (2) \| Respond to of 1577024

Obamacare is not failing, it is succeeding. Costs are rising more slowly than before, and more people are insured, and medical bankruptcy has been reduced. But costs are nonetheless rising unacceptably. Personally, I am not for single payer, but drug companies should not be allowed to charge anything the market will bear for life-changing and life-saving medicines. Something may be wrong with the cost unregulated free market in how it works with our present patent protections system in that it permits gouging that is passed onto all medical consumers for the life-saving or life altering treatments of a minority of patients. If the market can't be made to address this though competition among regulated insurance providers, then single payer or other policies that could only be labeled more "socialist" in nature - may be the way to go to contain costs and achieve maximum coverage and best treatments for all. Single payer may be a strong threat to yield against big pharma, but in the end I don't think this is the best way to go. Neither is unregulated free markets. I am a strong Obamacare supporter.